Sundaram Preethi bought CPRX

November 20, 2025 · Form 4 insider transaction

Sundaram Preethi bought 106,873 shares of Cameron Pharmaceutical Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction

Acquired (buy-side)

106,873

Price

$0.00

Total value

N/A

InsiderSundaram Preethi

Role—

CompanyCameron Pharmaceutical Inc (CPRX)

SecurityOptions to purchase common stock

Transaction codeA — Grant or award

Transaction dateNovember 20, 2025

Filing dateNovember 24, 2025

Shares owned after785,305

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Derivative securities vest in equal tranches, 1/3rd on November 20, 2026, 1/3rd on November 20, 2027 and 1/3rd on November 20, 2028.

View the original Form 4 on SEC EDGAR